Preliminary Baseline Subject Demographics and Disease Characteristics in a Phase 3 Clinical Trial of the Safety and Efficacy of Lenabasum in Dermatomyositis (DETERMINE) Werth, V., Oddis, C., Fiorentino, D., Dgetluck, N., Quinn Dinh, Tillinger, M., White, B., Lundberg, I. WILEY. 2020

View details for Web of Science ID 000587568505143